Cargando…
A high-throughput screen of pharmacologically active compounds for inhibitors of UHRF1 reveals epigenetic activity of anthracycline derivative chemotherapeutic drugs
DNA methylation can mediate epigenetic silencing of tumor suppressor and cancer protective genes. The protein ubiquitin-like containing PHD and ring finger domains 1 (UHRF1) is an essential component in cells for DNA methylation maintenance. The SET- and RING-associated (SRA) domain of UHRF1 can bin...
Autores principales: | Giovinazzo, Hugh, Walker, David, Wyhs, Nicolas, Liu, Jianyong, Esopi, David M., Vaghasia, Ajay M., Jain, Yash, Bhamidipati, Akshay, Zhou, Jianya, Nelson, William G., Yegnasubramanian, Srinivasan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508961/ https://www.ncbi.nlm.nih.gov/pubmed/31105884 http://dx.doi.org/10.18632/oncotarget.26889 |
Ejemplares similares
-
UHRF1 depletion sensitizes retinoblastoma cells to chemotherapeutic drugs via downregulation of XRCC4
por: He, Heng, et al.
Publicado: (2018) -
AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination
por: Haffner, Michael C., et al.
Publicado: (2017) -
The UHRF protein family in epigenetics, development, and carcinogenesis
por: UNOKI, Motoko, et al.
Publicado: (2022) -
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
por: Esopi, David, et al.
Publicado: (2020) -
Resistance to different anthracycline chemotherapeutics elicits distinct and actionable primary metabolic dependencies in breast cancer
por: McGuirk, Shawn, et al.
Publicado: (2021)